Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding showed higher levels of certain genes linked to hair loss and possibly prostate cancer.

Targeting 5α-reductase type 1 may help manage Tourette-like symptoms.

The role of 5α-reductase-3 in prostate cancer is unclear and needs more research.

Type 3 5α-reductase is more common and finasteride and dutasteride strongly inhibit it.

Avicequinone C, a compound found in the Avicennia marina plant, can reduce hair loss by inhibiting a hormone linked to androgenic alopecia.

Two types of 5α-reductase are in dog skin, which might make dutasteride better than finasteride for treating dog hair loss.

Some men's prostate tissues have low enzyme levels due to genetic changes, possibly affecting treatment for prostate enlargement.

Accurate protein modeling can help develop new treatments for prostate cancer and other diseases.

Prostaglandins and the enzyme AKR1C3 could play a role in skin cancer and hair loss, and further research is needed to understand these mechanisms.

5α-Reductase inhibitors can negatively impact sexual function.

Human bone cells mainly produce a type 1 enzyme that may help regulate bone health.

FGF5 gene mutations cause unusually long eyelashes by affecting hair growth regulation.

Natural 5α-reduced glucocorticoids might be anti-inflammatory with fewer side effects than current options.

Type 2 5α-reductase plays a key role in hair loss.

Certain hydroxycinnamate derivatives may effectively inhibit enzymes linked to hair loss with low toxicity.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Genetic differences within ethnic groups may affect prostate cancer treatment effectiveness.

A new genetic mutation linked to CARASIL syndrome and small artery disease was found in a Chinese family.

Coffee extract and caffeotannic acid can help treat hair loss.

New steroidal compounds moderately block an enzyme related to testosterone conversion, less effectively than finasteride.

Natural 5AR inhibitors effectively improve mild to moderate hair loss in men.

Higher CRHR1 levels in AA patients lead to increased inflammation.

The enzyme type 1 5α-reductase is more active in the hair follicle's lower part than in the skin's outer layer.

A new compound effectively inhibits human 5α-reductase 1.

Targeting the protein Caveolin-1 might help treat a type of scarring hair loss called Frontal Fibrosing Alopecia.

CXXC5 can both suppress and promote cancer, making it a complex target for treatment.